To explore the effects of acetylcysteine combined with polyene phosphatidylcholine on the levels of oxidative stress (OS) products, serum transforming growth factor (TGF)-β1 and free fatty acids (FFA) in patients with hyperthyroid liver injury.
Clinical data of 94 patients with hyperthyroidism liver injury admitted to department of endocrinology, the NO.2 hospital of Baoding from January 2020 to March 2021 were retrospectively analyzed, and were divided into observation group and control group according to random number table method, with 47 cases in each group. On the basis of conventional treatment, the control group was treated with polyene phosphatidylcholine capsules, and the observation group was treated with acetyl cysteine injection on the basis of the control group, and the treatment lasted for 4 weeks. Alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin (TBiL), γ-glutamyl transpeptidase (γ-GT), OS product [superoxide dismutase (SOD), malondialdehyde (MDA), glutathione peroxidase (GSH-Px)], serum TGF-β1, FFA level changes and adverse reactions were compared between the two groups.
The total effective rate of the observation group was higher than that of the control group (89.36% vs 61.70%), the difference was statistically significant (P<0.05). The levels of ALT, AST, TBiL and γ-GT in the observation group were lower than those in the control group, and the differences were statistically significant (P<0.05). The SOD and GSH-Px levels in the observation group were higher than those in the control group, while the MDA level was lower, and the differences were statistically significant (P<0.05). Serum TGF-β1 and FFA levels in the observation group were lower than those in the control group, and the differences were statistically significant (P<0.05).
Acetylcysteine combined with polyene phosphatidylcholine had significant efficacy in the treatment of patients with hyperthyroidism liver injury, which could help to positively regulate the levels of OS products, serum TGF-β1 and FFA, and promote the recovery of liver function. It was worthy of clinical promotion.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |